Thermo Fisher Scientific has launched a new handheld X-ray fluorescence analyser called IonicX XRF Analyzer to help pharmaceutical and biopharmaceutical manufacturers to verify the identity of ionic salts in warehouses within seconds. According to the […]
SMi Reports: RNA Therapeutics conference and focus day to return on February 2020, in London SMi Group is proud to announce the return of RNA Therapeutics conference for its 11th year, commencing on 18th – […]
SMi Reports: A panel discussion has been set for the 12th annual Pre-Filled Syringes and Injectable Drug Devices conference to be held in London on the 15th and 16th January. The 12th annual Pre-Filled Syringes […]
Merck has announced that Keytruda has been approved by the Chinese National Medical Products Administration (NMPA) as a monotherapy for first-line treatment of local advanced or metastatic non-small cell lung cancer (NSCLC). Keytruda’s approval was […]
AstraZeneca and Merck have presented full progression-free survival (PFS) results from the Phase III PAOLA-1 study of their PARP inhibitor Lynparza (olaparib) in newly-diagnosed ovarian cancer patients at the European Society of Medical Oncology congress. […]